- Home
- GTY vs XNCR Comparison
GTY vs XNCR Comparison
Compare GTY & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GTY | XNCR |
|---|---|---|
| Founded | 1955 | 1997 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.0B |
| IPO Year | 1998 | 2013 |
Fundamental Metrics
Financial Performance| Metric | GTY | XNCR |
|---|---|---|
| Price | $32.61 | $25.33 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 5 | 9 |
| Target Price | ★ $32.60 | $22.33 |
| AVG Volume (30 Days) | 370.3K | ★ 1.3M |
| Earning Date | 04-22-2026 | 05-08-2026 |
| Dividend Yield | ★ 5.92% | N/A |
| EPS Growth | 8.00 | ★ 65.36 |
| EPS | ★ 0.79 | N/A |
| Revenue | ★ $221,727,000.00 | $125,576,000.00 |
| Revenue This Year | $9.39 | N/A |
| Revenue Next Year | $7.83 | $4.80 |
| P/E Ratio | $41.18 | ★ N/A |
| Revenue Growth | 9.02 | ★ 13.65 |
| 52 Week Low | $25.39 | $8.29 |
| 52 Week High | $36.83 | $30.61 |
Technical Indicators
Market Signals| Indicator | GTY | XNCR |
|---|---|---|
| Relative Strength Index (RSI) | 40.85 | 52.14 |
| Support Level | $32.56 | $11.20 |
| Resistance Level | $33.90 | $30.61 |
| Average True Range (ATR) | 0.50 | 1.68 |
| MACD | -0.01 | -0.52 |
| Stochastic Oscillator | 32.45 | 6.01 |
Price Performance
Historical ComparisonAbout GTY Getty Realty Corporation
Getty Realty Corp is a net lease real estate investment trust in the U.S.A, specializing in the acquisition, financing, and development of convenience, automotive, and other single-tenant retail real estate. The company's portfolio includes convenience stores, express tunnel car washes, automotive service centers (gasoline and repair, oil and maintenance, tire and battery, and collision), drive-thru quick service restaurants, and certain other freestanding retail properties. It generates maximum revenue in the form of rental income.
About XNCR Xencor Inc.
Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.